Kidney injury in COVID-19
A. R. Ahmed, Chaudhry Adeel Ebad, Sinéad Stoneman, M M Satti, Peter J. Conlon
Abstract
Coronavirus disease 2019 (COVID-19) continues to affect millions of people around the globe. As data emerge, it is becoming more evident that extrapulmonary organ involvement, particularly the kidneys, highly influence mortality. The incidence of acute kidney injury has been estimated to be 30% in COVID-19 non-survivors. Current evidence suggests four broad mechanisms of renal injury: Hypovolaemia, acute respiratory distress syndrome related, cytokine storm and direct viral invasion as seen on renal autopsy findings. We look to critically assess the epidemiology, pathophysiology and management of kidney injury in COVID-19.
Topics & Concepts
MedicineAcute kidney injuryCytokine stormCoronavirus disease 2019 (COVID-19)Incidence (geometry)Intensive care medicineKidneyEpidemiologyAutopsyDiffuse alveolar damagePathophysiologyAcute respiratory distressRespiratory distressKidney diseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ARDSDiseasePathologyInternal medicineLungInfectious disease (medical specialty)SurgeryOpticsPhysicsMuscle and Compartmental DisordersAcute Kidney Injury ResearchCOVID-19 Clinical Research Studies